Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.

Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.

Patients with chronic kidney disease, especially those undergoing dialysis treatment and having secondary hyperparathyroidism, have a high risk of bone fracture. The renin-angiotensin system (RAS) is associated with osteoclastic bone resorption. We aimed to examine whether the use of RAS inhibitors...

Full description

Bibliographic Details
Main Authors: Suguru Yamamoto, Ryo Kido, Yoshihiro Onishi, Shingo Fukuma, Tadao Akizawa, Masafumi Fukagawa, Junichiro J Kazama, Ichiei Narita, Shunichi Fukuhara
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395204?pdf=render

Internet

http://europepmc.org/articles/PMC4395204?pdf=render

Similar Items